(Date:9/5/2008)...s the Latest Developments in Molecular,Testing and... /PRNewswire-USNewswire/ -- The practice of,pathol...g and the promise,of personalized medicine will ch...and other imaging technologies will change the way...ogists is taking a leadership role in,making sure ...
(Date:9/5/2008)...RNewswire-USNewswire/ -- The Health Resources,and ... million in grants to,increase and improve medical... grants continue President Bush,s historic expansi...w reach more economically,vulnerable and geographi...dministrator Elizabeth M. Duke said. "In 2007, mor...
(Date:9/5/2008)...tical ,anti-cloak, could bring objects out of hidi...-- Just in case someone develops a cloak of invisi... how to uncloak the objects it hides. , Accordi...in materials underneath an invisibility cloak woul...esearchers at Shanghai Jiao Tong University in Chi...
(Date:9/5/2008)...ain to commit to develop a National AIDS,Strategy ...p. 5 /PRNewswire-USNewswire/ -- The,Republican Nat...ion of the,domestic AIDS epidemic in the United St...erseas. Neither Presidential nominee Sen. John McC... mentioned AIDS in their remarks,to Convention del...
Breaking Medicine News(10 mins):Health News:Leaders in Pathology Meet in San Diego: Sept. 25 - 28, 2008 2Health News:HRSA Announces $39 Million in Grants to Expand, Improve Health Center Services 2Health News:Domestic AIDS Epidemic Ignored at Republican National Convention 2Health News:Domestic AIDS Epidemic Ignored at Republican National Convention 3...al officials in the United States are worried that...event of an outbreak of the deadly bird flu//. Hea...e measures to be taken if any sick passengers are ...als are vested with authority to take quick measur...
...oth victims of bully and children’s involved in bu...ersity of Washington reported in the Journal Archi...chologically both the group of children’s was stre...350 students studying in three, four and five stud...
...ed in Armonk, N.Y., announced this Tuesday its dec...as part of an overall effort to help accelerate ca... collaborate with the Memorial Sloan-Kettering Can...tute and the CHU Sainte-Justine Research Center un...
...hock waves in the industry pertaining to Lycopene ... Food and Drug Administration to American Longevit...ed health claims for lycopene, tomatoes, and tomat...lycopene. The proposed health claims say lycopene ...
Other Medicine News:Health News:Crusade Against Cancer: Collaborations On The Anvil 2(Date:9/4/2008)...or Targeted Therapies That Ensure Ben...H, Calif., and AMSTERDAM, Netherlands, Sept. 4,/PR...cancer diagnostics,today announced the launch of ...physicians to quantitatively determine the gene ex...gesterone receptor (PR) and Human Epidermal,growth...
(Date:9/3/2008)...re-FirstCall/ --,Pharmaceutical company Pharmaxis ...as enrolled the first subject into its second pivo...n cystic fibrosis sufferers., The Phase 3 trial i...rica, Argentina and Germany, and is the final clin...t Bronchitol for cystic fibrosis in the,United Sta...
(Date:9/3/2008)...ll/ -- Simcere,Pharmaceutical Group (NYSE: SCR ),...neric pharmaceuticals and manufacturer of the pate...as Endostar) in China,announced the interim resul...st of the SFDA, Simcere initiated a Phase IV clini...peutic efficacy of Endu, a modified,version of rec...
(Date:9/3/2008)...lly infected Hepatitis C,patients strongly confirm..., - Study is the first to show a statistically s...f therapeutic Hepatitis C vaccination, - Data pa... generation, vaccine formulated with Intercell,s ... activation, VIENNA, Austria, Sept...
Breaking Medicine Technology:Agendia Launches TargetPrint(R) for Breast Cancer Patients 2Second Pivotal Phase 3 Trial In Cystic Fibrosis Begins 2Second Pivotal Phase 3 Trial In Cystic Fibrosis Begins 3Simcere Pharmaceutical Group Announces Interim Results of Endu Phase IV Clinical Study 2Simcere Pharmaceutical Group Announces Interim Results of Endu Phase IV Clinical Study 3Favourable Six Months Follow-Up Results From Intercell's Phase II Therapeutic Hepatitis C Program 2Favourable Six Months Follow-Up Results From Intercell's Phase II Therapeutic Hepatitis C Program 3Favourable Six Months Follow-Up Results From Intercell's Phase II Therapeutic Hepatitis C Program 4Shire investigational nonstimulant INTUNIV showed significant efficacy in reducing ADHD symptoms 18700 1Shire investigational nonstimulant INTUNIV showed significant efficacy in reducing ADHD symptoms 18700 2UCI awarded 2427 2 million for new stem cell building 3225 1UCI awarded 2427 2 million for new stem cell building 3225 2UCI awarded 2427 2 million for new stem cell building 3225 3Insurance Department Fines Conseco Under Pennsylvania Led Multi State Agreement 18697 1Insurance Department Fines Conseco Under Pennsylvania Led Multi State Agreement 18697 2Insurance Department Fines Conseco Under Pennsylvania Led Multi State Agreement 18697 3Bipartisan Group of Senators and Representatives Introduce Bill to Battle Brain Related Illness 18693 1Bipartisan Group of Senators and Representatives Introduce Bill to Battle Brain Related Illness 18693 2Bipartisan Group of Senators and Representatives Introduce Bill to Battle Brain Related Illness 18693 3Bipartisan Group of Senators and Representatives Introduce Bill to Battle Brain Related Illness 18693 4...ue to water damage caused by,flooding over the wee...or the upcoming Antiviral Drugs Advisory Committee...lication for,maraviroc 300 milligram tablets. Orig... Drug Evaluation and Research Advisory Committee,C...lle, MD, the,meeting has been relocated to , Crown...
...wswire/ -- Sirion Therapeutics,Inc., an ophthalmi...ay that it has received orphan drug designation fr...anti-viral therapy,ganciclovir, for the treatment...ntly marketed by Laboratoires Thea in Europe under...rights to,Virgan(R) for the United States from Lab...
Other Medicine Technology:FDA Announces Change of Location Notice for Upcoming Advisory,Committee Meeting 2Sirion Therapeutics Receives Orphan Drug Designation for Ophthalmic,Drug to Treat Viral Eye Infection 2Angled 13.5 mm adjustable blades. Teeth in lower jaws fit into holes in upper jaws. Grooves in lower jaw for passage of suture needles. Round knurled handle with polished finish.
Multi-curved shafts with straight blades and longitudinal serrations. Slide lock and serrated handle with polished finish. Blade length: 27 mm.
Straight shafts with 5.5 mm tying platform and 1 mm crisscross serrated tips. Wide serrated handle with polished finish.
Smooth pointed tips open to 3.0 mm. Straight shafts. Cross action. Round handle.
Medicine Products: